COVID-19 in pediatric patients from Pinar del Rio province
Keywords:
CORONAVIRUS, EPIDEMIOLOGY, RESPIRATORY SYSTEM, CHILD, MOLECULAR BIOLOGY, PEDIATRICS.Abstract
Introduction: coronaviruses are named for the peculiar crown-shaped viral particles that cover their surface, several species are newly investigated and there is little information about transmission, severity and clinical effects.
Objective: to characterize pediatric patients with COVID-19 attended in Pinar del Río province.
Methods: an observational, descriptive and cross-sectional study of 15 patients with COVID-19 admitted to Dr. Leon Cuervo Rubio Clinical-Surgical Teaching Hospital was conducted from March 26th to May 12th, 2020. The studied was completed by means of a non-probabilistic sampling. Descriptive statistical methods were applied to process the information collected.
Results: the most represented age group was 7-12 years old and male gender (60 vs. 40 %); 53.3% of patients developed a non-complicated infection and bronchial asthma was the most frequent comorbidity. The most reported symptom on admission was fever (60 %). In the chest X-ray the hilar thickening showed a greater presentation, without significant alterations in the laboratory studies. The total number of cases studied was treated with oral Oseltamivir.
Conclusions: COVID-19 has rapidly become a global health threat. Male schoolchildren were more prone to infection and the disease presented non-severe clinical syndromes.
Downloads
References
1. Avila de Tomás JF. Coronavirus Covid-19; Patogenia, prevención y tratamiento [Internet] 2da Ed. Salusplay editorial. Pais Vazco; 2020 [Actualizado 2020; Citado 5/5/2020]. Disponible en: https://ebevidencia.com/wp-content/uploads/2020/03/CORONAVIRUS-COVID-19_-patogenia-prevenci%C3%B3n-y-tratamiento-2%C2%AA-Ed-15.03.2020-ISBN-978-84-16861-95-8-.pdf
2. Sociedad Argentina de Virología. División de la Asociación Argentina de Microbiología. INFORME SARS COV-2 [Internet]. SAV; 2020. [Citado 5/5/2020]. Disponible en: https://aam.org.ar/src/img_up/22032020.0.pdf
3. Tinku J, Mohammed A. International Pulmonologist´s Consensus on COVID-19 [Internet]. Amrita Institute of Medical Sciences and Research Centre; March 2020. [Citado 5/5/2020]. Disponible en: https://www.researchgate.net/publication/340666754_International_Pulmonologist's_consensus_on_COVID-19
4. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet [Internet]. 2020 [Citado 5/5/2020]; 395(10229): [aprox. 1p.]. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext
5. Centro de Coordinación de Alertas y Emergencias Sanitarias. Documento técnico Manejo clínico de pacientes con enfermedad por el nuevo coronavirus (COVID-19) [Internet]. España; 2020 [Citado 5/5/2020]. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Manejo_primaria.pdf
6. Gauna ME, Bernava JL. Recomendaciones diagnósticas y terapéuticas ante la Respuesta Inmune Trombótica Asociada a Covid-19 [Internet]. RITAC; 2020 [Citado 5/5/2020]. Disponible en: https://fundacionio.com/wp-content/uploads/2020/04/Si%CC%81ndrome-RITAC.pdf.pdf.pdf.pdf.pdf.pdf.pdf
7. Olmos GC, Cepeda SJ, Zenteno AD. NUEVO CORONAVIRUS (COVID-19) EN POBLACIÓN GENERAL Y PEDIÁTRICA: UNA REVISIÓN EPIDEMIOLÓGICA. CHILE 2020. Neumol Pediat [Internet]. 2020 [citado 5/5/2020]; 15(2): [aprox. 7p.]. Disponible en: https://www.neumologia-pediatrica.cl/wp-content/uploads/2020/05/2020-15-2-2-es.pdf
8. Calvo C, García López-Hortelano M, de Carlos Vicented JC, Vázquez Martínez JL, Grupo de trabajo de la Asociación Española de Pediatría para el brote de infección por Coronavirus, colaboradores con el Ministerio de Sanidad. Recomendaciones sobre el manejo clínico de la infección por el nuevo coronavirus SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP). An Pediatr (Barc) [Internet]. 2020 [citado 5/5/2020]; 92(4): [aprox. 11p.]. Disponible en: https://www.analesdepediatria.org/es-recomendaciones-sobre-el-manejo-clinico-articulo-S169540332030076X
9. Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet [Internet]. 2020 [citado 5/5/2020]; 395(10229): [aprox. 9p.]. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext
10. CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19), United States, February 12- March 16, 2020. [Internet ]MMWR; 2020 [Citado 5/5/2020]; 69(12): [aprox. 3p.]. Disponible en: https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm
11. AEPap-SEIP, AEP-SEPEAP. MANEJO DEL PACIENTE PEDIÁTRICO ANTE SOSPECHA DE INFECCIÓN POR EL NUEVO CORONAVIRUS SARS-CoV-2 EN ATENCIÓN PRIMARIA (COVID-19) [Internet]. AEP; 2020 [citado 5/5/2020]. Disponible en: https://www.aeped.es/noticias/manejo-paciente-pediatrico-ante-sospecha-infeccion-por-nuevo-coronavirus-sars-cov-2-en-atencion
12. Hosseiny M, Koorak S, Gholamrezanezhad A, Reddy S. Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome American Journal of Roentgenology [Internet]. 2020 [citado 5/5/2020]; 214(5): [aprox. 4p.]. Disponible en: https://www.ajronline.org/doi/full/10.2214/AJR.20.22969
13. Liu Xing Z, Xue Za Zhi B. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) China, 2020. PubMed [Internet]. 2020 [citado 5/5/2020]; 41(2): [aprox. 6p.]. Disponible en: https://www.unboundmedicine.com/medline/citation/32064853/[The_epidemiological_characteristics_of_an_outbreak_of_2019_novel_coronavirus_diseases__COVID_19__in_China]_
14. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.Signal Transduction and Targeted Therapy (2020) 5:33. Disponible en: https://www.researchgate.net/publication/340226548_Lymphopenia_predicts_disease_severity_of_COVID-19_a_descriptive_and_predictive_study
15. Sanders JM, Monogue ML, Jodlowski T, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). JAMA [Internet]. 2020 [citado 5/5/2020]; 323(18): [aprox. 12p.]. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2764727
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
